Introduction {#S1}
============

Legumes are particular because they can form symbiosis with nitrogen fixing bacteria, which convert the atmospheric nitrogen into ammonia and satisfy the nitrogen need of the host plant ([@B12]). The symbiotic rhizobium partners are soil-dwelling alpha- or beta-proteobacteria, which are present intracellularly in the symbiotic organ, the root nodule, and are called bacteroids. The bacteroid-containing nodule cells become polyploid, grow to an extreme size, and host thousands of bacteroids ([@B21]). In many legumes, the nitrogen fixing bacteroids are similar to cultured bacteria, which can change their lifestyle reversibly between the free-living and symbiotic states. In IRLC legumes or in certain legumes from the Dalbergioid clade, the bacteroids undergo an irreversible, terminal differentiation. This terminal differentiation is associated with definitive loss of cell division potential, changes in the membrane composition and permeability, cell growth from moderate to extreme sizes coupled to genome amplification, altered cell morphology ([@B27]; [@B29]), and more efficient nitrogen fixation ([@B31]). To accomplish this, legumes have evolved a spectacular arsenal of antimicrobial peptides (AMPs) which are targeted to the bacteroids and provoke their differentiation ([@B25]; [@B39]). In the IRLC legumes, the NCR peptides, while in Dalbegioids, the convergently evolved NCR-like peptides represent the vast majority of these host effectors ([@B45]; [@B8]; [@B29]; [@B44]).

The *NCR* genes are expressed in the symbiotic nodule cells but in different subsets at sequential stages of the differentiation process ([@B24]; [@B13]). Immunogold localization and proteome of isolated bacteroids demonstrated undoubtably the presence of NCR peptides in the bacteroids ([@B45]; [@B9]). NCRs are present in all members of the IRLC, but the size and composition of the family vary dramatically among the species from 7 up to ∼700 NCRs ([@B29]). In line with the complexity of the NCR family, the morphotype of bacteroids can be swollen, spherical, elongated or both elongated, and branched in different legumes ([@B29]).

The Structure of NCR and NCR-Like Peptides and Their Relatedness to Defensins {#S2}
=============================================================================

There are ∼700 *NCR* genes in the model legume *Medicago truncatula.* The *NCR* genes are usually composed of two exons; the first one codes for a relatively conserved signal peptide while the second one for a highly diverse mature peptide, which contains four or six cysteine residues in conserved positions ([@B2]). In 95% of the NCRs, the length of the mature peptides varies between 24 and 65 amino acids but it is mostly 35--50 amino acid long in the majority of NCRs. [Figure 1A](#F1){ref-type="fig"} shows graphical representation of amino acids in multiple alignment of the mature NCR and NCR-like sequences with Jalview version 2.11.0 ([@B48]) and Clustal X version 2.1 ([@B23]) where the height of letters indicates the relative frequency of amino acids at each position ([@B7]). Beside the cysteines, only a few amino acids are present in \>60% of NCRs, such as the aspartic acid (D) in front of the second cysteine (C~2~) and between C~1~ and C~2~, or proline (P) after C~2~. Due to the high diversity of amino acid composition, the isoelectric points (pI) of the *M. truncatula* NCR peptides vary between 3.5 and 11.25. In *M. truncatula*, 35% of the NCRs are anionic, 23% neutral and 42% cationic and almost equal numbers of genes code for NCRs with four and six cysteines. The high sequence variation also applies to these subgroups. As illustrated for the cationic (pI \> 9) NCRs, the presence of the positively charged amino acids (K/R) is characteristic before C~2~ and in front of C~3~ and C~4~ in NCR 4Cs and 6Cs, respectively. Moreover, threonine (T) is frequent after C~1~X in NCR 4Cs but not in the 6Cs.

![The structure of NCRs, NCR-like peptides **(A)** and the mode of actions of cationic NCRs **(B)**. **(A)** Frequency of amino acids and conserved patterns of cysteines in the mature *M. truncatula* NCRs and NCR-like peptides from Dalbergioid legumes. The height of letters in the stacks indicates the relative frequency of (each amino acid at that position. Color code of amino acids: blue, positively charged (KR) residues; red, hydrophobic (AFILMV) and amphipathic (WY) residues; black, all other amino acids. The underlined G residue in the NCR-like peptides marks the beginning of the γ-core motif. **(B)** The mode of actions of cationic NCRs based on the example of NCR247 (Created with [BioRender.com](http://BioRender.com)). NCRs can interact with the bacterial membranes and enter the cytosol with or without pore formation or cause membrane damages and cell lysis. Intracellularly NCRs provoke global transcriptional changes and interact with numerous bacterial proteins that collectively affect essential cellular functions. The framed proteins BacA, HrrP, SMc03872, and polysaccharides EPS and LPS protect the symbiotic bacterium partner from the killing action of NCRs.)](fmicb-11-01307-g001){#F1}

The cysteines are essential for the symbiotic, *in planta* functions as replacement of a single cysteine with serine resulted in the inactivation of the *Medicago*-specific NCR169 peptide ([@B18]). Formation of disulfide bridges between the conserved cysteines could be important structural and functional elements of the NCR peptides. The disulfide bridges can be formed in the endoplasmic reticulum (ER) where enzymes controlling the oxidation of cysteines into disulfide bonds, such as the protein disulfide isomerase and ER oxidoreductin 1, are strongly upregulated ([@B26]; [@B38]). On the other hand, the symbiotic cells also produce symbiosis-specific thioredoxins that are co-targeted with the NCRs to the cytosol of bacteroids and can reduce the disulfide bonds of NCR peptides ([@B37]). These observations suggest that NCRs are oxidized in the ER but are reduced within the bacteroids at least partially ([@B1]). Accordingly, the redox state of the NCR peptides could represent a further level of complexity in regulating their activites.

The role of cysteines and disulfide bridges was primarily studied in the smallest, 24 amino acid long NCR247 using chemically synthetized peptides and the symbiotic bacterium partner *Sinorhizobium meliloti* in various bioassays. Exchanging the four cysteines for serines (NSR247), altering the position of the disulfide bridges, breaking the bridges by reduction (NCR247~red~) or omitting the cysteines, all affected but to a different extent the peptides' activities and stability ([@B16]; [@B42]). The disulfide bonds in NCR044 produced in the yeast *Pichia pastoris* were confirmed between C1--C4 and C2--C3, while the three dimensional structure of this peptide was found to be largely dynamic and disordered ([@B46]).

The NCR-like peptides in Dalbergioid legumes, like *Aeschynomene afraspera* and *Aeschynomene indica* are distinct from the IRLC NCRs but play similar roles in provoking terminal differentiation of bacteroids ([@B8]). The mature NCR-like peptides are ∼50 amino acid long and have six or eight conserved cysteines and a tryptophan (W) ([Figure 1A](#F1){ref-type="fig"}). These sequences are less divergent and several amino acids are present at \>60% frequency at given positions. The NCR-like peptides are anionic or neutral except for two mildly cationic ones.

NCRs and NCR-like peptides resemble defensins, the largest group of plant innate immunity effectors ([@B41]). Defensins are also secreted peptides with a length of approximately 45--54 amino acids and 8 or 10 conserved cysteines forming disulfide bonds ([@B33]). In spite of variations in the primary sequence, the 3D structure of defensins is conserved. Plant defensins have a γ-core motif (GXCX~3--9~C) that is a hallmark related to their antimicrobial properties ([@B49]). Interestingly, the γ-core motif is also present in the majority of NCR-like peptides ([Figure 1A](#F1){ref-type="fig"}).

Both the *NCR* and *NCR-like* genes might have originated from an ancestral defensin type gene by gene duplications and fast diversification. The NCR gene family evolution is probably driven by a continuous adaptation to diversifying rhizobium symbionts. In *M. truncatula*, *NCR* genes are present on all chromosomes, and beside long distance duplications, local duplications form small clusters of *NCR* genes. Since many *NCRs* are in the vicinity of transposable elements, transposons might have been involved in the multiplication of *NCR* genes ([@B40]).

Symbiotic Roles of *M. truncatula* NCR Peptides {#S3}
===============================================

In the very young symbiotic nodule cells where the endosymbionts multiply, only a few non-cationic *NCR* genes are expressed. When the endosymbiont population reaches a certain density, the endosymbionts enter the differentiation process starting with cell division arrest and cell enlargement ([@B21]). Changes also occur in the cell envelope and the increased membrane permeability can facilitate the exchange of metabolites between the plant and bacterium. If the differentiation process is incomplete, there is no nitrogen fixation.

One of the major tasks of the NCR peptides is to inhibit and permanently abolish the bacterial cell division. Treatment of *S. meliloti* cultures *in vitro* with synthetic NCRs revealed that cationic peptides like NCR035, NCR055, or NCR247 provoke increased membrane permeability, cell elongation, DNA amplification, and kill ultimately the bacteria ([@B45]). The mode of action of NCR247 is the best studied one ([Figure 1B](#F1){ref-type="fig"}). Its activation in the nodules coincides with the start of bacteroid differentiation; with cell division arrest and elongation of bacteroids ([@B10]). Treatment of *S. meliloti* cultures with 5 μM NCR247 damaged the integrity of bacterial membranes and led to cell death ([@B10]; [@B28]). Cysteines also contribute to the antimicrobial activity of NCR247 and the reduced form is the most effective ([@B16]; [@B42]). NCR247 as well as other cationic NCR peptides provoke formation of outer membrane vesicles ([@B29]) but NCR247 at sublethal 1.5 μM concentration, enters the cytosol without pore formation ([@B10]).

Treatment of log phase *S. meliloti* cultures or synchonized cells with sublethal concentrations of the reduced and the oxidized forms of NCR247 provoked global transcriptional changes affecting 14--15% of the protein coding sequences ([@B43]; [@B34]). Besides general stress response activation, nearly half of the cell cycle genes were affected including critical regulators, such as *dnaA*, *gcrA*, *ctrA* and those involved in septum formation and cell division. Genes involved in translation and particularly in ribosome biogenesis were downregulated. Expression of genes involved in transcriptional regulation, membrane modifications and transport were perturbed.

The Boman index (indicating the protein binding potential) of NCR247 is one of the highest among all known proteins and indeed it possesses extreme protein binding ability ([@B10]). Half of the ribosomal proteins and numerous proteins involved in different stages of translation were present in the NCR247 complexes leading to the inhibition of protein synthesis. Its interaction with FtsZ prevented the Z-ring formation and thereby septum assembly and bacterial cell division. Interestingly NCR035, another cationic NCR peptide coexpressed with NCR247, binds to the septum, suggesting that the host plant employs multiple peptides to interfere with specific biological processes, such as the bacterial cell division. NCR247 interacts also with the GroEL chaperone, which is essential for the differentiation of symbiotic cells though it is unknown how the binding of NCR247 affects GroEL functions. Treatment of *S. meliloti* cultures with the most cationic peptide, NCR335, resulted, similarly, in rapid downregulation of genes involved in basic cellular functions, such as transcription-translation and energy production, as well as upregulation of genes involved in stress and oxidative stress responses and membrane transport ([@B43]).

While cationic NCRs exhibited toxicity *in vitro* for rhizobia, none of the tested anionic peptides, except for NCR211 affected the survival of rhizobia ([@B20]). At present it is unkown how NCR211 and the non-cationic NCR-like peptides exert antimicrobial properties.

In the nodule cells, the rhizobia are viable and are likely to be exposed to lower concentrations of NCRs than those used in the *in vitro* assays. Moreover, the bacteria have evolved various mechanisms against the toxicity of NCRs. BacA is essential for the survival of bacteroids in *M. truncatula* ([@B15]). BacA is an ABC transporter protein, which promotes uptake and translocation of NCRs from the membrane to the cytosol that might diminish the membrane damage and keep the bacteria alive ([@B14]; [@B6]). Components of the cell envelope also provide protection, such as lipopolysaccharides (LPS) together with the BacA mediated synthesis of very long chain fatty acids (VLCFA), high molecular weight succinoglycans in the exopolysaccharide (EPS) layer and other membrane constituents ([@B4], [@B3]; [@B29]). Proteolytic degradation of NCRs by the bacterial HrrP and SMc03872 represents another level of resistance ([@B36]; [@B4]) though the oxidized forms are more stable ([@B42]).

Antibacterial Spectrum of NCRs {#S4}
==============================

Cationic NCRs are in many respects similar to membrane-permeabilizing cationic antimicrobial peptides whose net charge ranges from +2 to +9 and facilitaties their interaction with the negatively charged bacterial membranes. Most antibacterial tests have been carried out with NCR247 (net charge +6) and NCR335 (net charge +14) which were classified with four and two different AMP prediction tools as AMPs, respectively ([@B11]). NCR335 is unusual because it is 64 amino acid long and only its C-terminal half carries the conserved cysteine pattern of NCRs. The antimicrobial activity of chemically synthetized NCRs has been tested against a broad panel of Gram-negative (*Escherichia coli*, *Salmonella enterica*, *Pseudomonas aeruginosa*, *Pseudomonas syringae* pv. *tomato*, *Xanthomonas campestris*, *Agrobacterium tumefaciens*, *Chlamydia trachomatis*) and Gram-positive (*Bacillus megaterium*, *Bacillus cereus*, *Bacillus subtilis*, *Listeria monocytogenes*, *Staphylococcus aureus*, *Clavibacter michiganensis*) bacteria, including diverse human/animal and plant pathogens. The peptides, added to 10^7^, bacteria for 3 h, killed to various extent all these tested bacteria resulting in their complete elimination or decrease in the number of surviving cells from one to several orders of magnitude, depending on the strain and the peptide ([@B43]; [@B5]). In general, cationic NCR peptides with pI \>9.0 seem to have antibacterial activities, however, their antimicrobial spectrum was only partially overlapping indicating that in addition to their positive charge, their amino acid composition and primary sequence also contribute to the strength and spectrum of antibacterial activities. Due to the multiple bacterial targets of NCRs, there is little chance for development of resistance against them.

Antibacterial Potential of NCR247-Based Chimeric Peptides Is Comparable to Third Generation Antibiotics {#S5}
=======================================================================================================

Skin and soft tissue infections are mainly caused by ESKAPE bacteria which are resistant to most antibiotics ([@B35]). Based on the different mode of action and broad spectrum of NCRs it is conceivable that they may also be able to kill these resistant pathogens. The antibacterial activity of chemically synthesized NCR247 and NCR247-derivatives was investigated against ESKAPE strains (*Enterococcus faecalis*, *S. aureus*, *Klebsiella pneumoniae*, *Acinetobacter baumannii*, *P. aeruginosa*) and *E. coli, L. monocytogenes*, and *S. enterica* ([@B19]; [Table 1](#T1){ref-type="table"}). The minimal bactericidal concentration of NCR247 was 3.1 μM against *P*. *aeruginosa* and 6.3 μM against *S. aureus* and *E. coli* while killing of the other bacteria required higher concentrations. The C-terminal half of NCR247 (NCR247C) retained its activity on *E. coli* but lost its effectiveness on other bacteria. To improve its antimicrobial properties, NCR247C was fused with NCR335~7--19~ (X1) or mastoparan~4--14~ (X2) deriving from the 14 amino acid long mastoparan, a membranolytic peptide toxin from wasp venom. Each of these chimeric peptides possessed higher antibacterial efficacy and affected the antimicrobial spectrum. In the case of X1-NCR247C the minimal bactericidal concentrations (MBC) varied between 1.6 and 12.5 μM. C- or N-terminal fusion of NCR247C with X2 made the chimeric peptides very effective on most strains at 1.6 and 3.1 μM MBCs. The MBCs of these chimeric derivatives were much lower than that of the classical antibiotic carbenicillin, and were comparable or even more effective than levofloxacin, a third generation antibiotic ([@B19]).

###### 

The amino acid sequence of NCR247 and its derivatives (A) and the minimal bactericidal concentrations (MBCs) of these peptides and antibiotics (in μM) on different pathogens (B) (from [@B19]).

  **(A)**                    **Name**                                 **Amino acid sequence**                                                                               
  -------------------------- ---------------------------------------- ------------------------------- ------------- ------------- ------------- ------------- ------------- -------------
                             NCR247                                   RNGCIVDPRCPY**QQCRRPLYCRRR**                                                                          
                             **NCR247C**                              **QQCRRPLYCRRR**                                                                                      
                             **X1** (NCR335~7--19~)-**NCR247C**       RPLNFKMLRFWGQ**QQCRRPLYCRRR**                                                                         
                             **NCR247C**-**X2** (Mastoparan~4--14~)   **QQCRRPLYCRRR**KALAALAKKIL                                                                           
                             **X2** (Mastoparan~4--14~)-**NCR247C**   KALAALAKKIL**QQCRRPLYCRRR**                                                                           
                             **X2** (Mastoparan~4--14~)               KALAALAKKIL                                                                                           
                                                                                                                                                                            
  **(B)**                                                                                                                                                                   
                                                                                                                                                                            
  **Peptides/Antibiotics**   ***E. f.***                              ***S. a.***                     ***K. p.***   ***A. b.***   ***P. a.***   ***E. c.***   ***L. m.***   ***S. e.***
                                                                                                                                                                            
  NCR247                     \>25                                     **6.3**                         \>25          12.5          **3.1**       **6.3**       \>25          25
  NCR247C                    \>25                                     \> 25                           \>25          25            25            **6.3**       \>25          \> 25
  **X1-NCR247C**             **6.3**                                  **3.1**                         12.5          **3.1**       **3.1**       **3.1**       **3.1**       **1.6**
  **NCR247C-X2**             25                                       **3.1**                         **6.3**       **3.1**       **3.1**       **1.6**       **1.6**       **1.6**
  **X2-NCR247C**             **3.1**                                  **3.1**                         **6.3**       **3.1**       **3.1**       **3.1**       **3.1**       **3.1**
  **X2**                     \>25                                     25                              \>25          25            **6.3**       \>25          25            \>25
  **Cb**                     5120                                     640                             \>10,240      5120          10240         1280          80            640
  **Lvx**                    160                                      **2.5**                         320           20            **1.3**       **5.0**       320           **1.3**

E. f., Enterococcus faecalis; S. a., Staphylococcus aureus; K. p., Klebsiella pneumoniae; A. b., Acinetobacter baumannii; P. a., Pseudomonas aeruginosa; E. c., Escherichia coli; L. m., Listeria monocytogenes; S. e., Salmonella enterica. Cb, carbenicillin; Lvx, levofloxacin. MBCs below 10 μM are in bold.

The killing activity of the NCR247-based chimeric peptides occurred within 0.1--5 min. While the antimicrobial activity of cationic peptides is generally attenuated by the presence of divalent cations and higher salt concentrations ([@B17]), the bactericidal activity of these chimeric peptides was maintained in Mueller Hinton broth. Importantly, these peptides did not have hemolytic activity or cytotoxicity on human cells ([@B19]).

Antifungal Activity of NCRs {#S6}
===========================

The relatedness of NCRs to antimicrobial peptides, particularly to plant defensins protecting the plants mostly against fungal infections suggests that NCRs also have antifungal activity. Among 19 NCR peptides with pI ranging from 3.61 to 11.22, nine with pI \>9.5 inhibited the growth and the survival of both the yeast and filamentous forms of *Candida albicans*, one of the most common opportunistic human pathogens ([@B32]). The minimal fungicidal concentrations of the most effective peptides (NCR335, NCR044) were between 1 and 3 μM. Treatment of *C. albicans*-infected vaginal epithelial cells with NCR335, NCR247, or NCR192 for 3 h prevented epithelial cell death induced by *C. albicans*. The concentrations required for killing the fungus did not affect survival of human cells. The anticandidal activity of NCR peptides was achieved by permeabilization of the fungal membrane and interactions with multiple intracellular targets. Cationic NCR peptides were also active on *Aspergillus niger, Candida crusei, Candida parapsilosis, Fusarium graminearum*, *Rhizopus stolonifer var. stolonifer*, however, their antifungal spectrum and efficacity varied indicating that, similarly, to the bactericidal action, in addition to the pI, the amino acid sequence also contributes to the antifungal properties ([@B22]). NCR044 exhibited strong fungicidal activity against the plant pathogen *Botrytis cinerea* and several *Fusarium* species ([@B46]). The inhibitory concentration of NCR044 varied between 0.52 and 1.93 μM. NCR044 interacts with the *B. cinerea* cell wall and the membrane phospholipids, then it translocates to the cytoplasm and localizes to the nucleolus. It provokes production of reactive oxygen species and might interfere with protein synthesis. Thus, both the antibacterial and the antifungal activities of NCRs rely on multistep actions. In lettuce leaves and rose petal assays, NCR044 provided resistance to *B. cinerea*. These findings together with the economical production of NCR044 in *P. pastoris* paves the way to use NCRs in agriculture for plant protection ([@B46]).

Conclusion {#S7}
==========

Antimicrobial resistance is a global healthcare threat. Many people die from incurable infections and with the lack of appropriate antibiotics we might return to the pre-antibiotic era. AMPs represent a new hope with their rapid killing and broad spectrum activity against multidrug resistant (MDR) pathogens. AMPs, like the cationic NCRs, are multifunctional. They can interact with the membranes with or without membrane permeabilization and intracellularly they can affect transcription, translation, enzyme activities causing ultimately microbial death ([@B30]). A few AMPs with potent activity against MDR species are in clinical use like colistin, one of the last-resort drugs ([@B35]; [@B30]). Toxicity of AMPs is, however, a major drawback and many AMPs are limited to topical application. To the 3011 AMPs in the antimicrobial peptide database ([@B47]), legumes can add several ten thousands of natural AMPs produced in the symbiotic cells. Legumes are mostly edible plants and NCRs are apparently not toxic for human cells while many of them kill pathogenic bacteria and fungi very effectively with multi-target actions. In laboratory conditions, NCRs or their derivatives, such as various chimeric peptides have similar or even superior antimicrobial properties than third generation antibiotics. Exploring their potential might help to fight against existing and unforeseen bacterial, fungal and possibly viral infections both in medicine and agriculture.
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